other material
confidence high
sentiment neutral
materiality 0.45
Immix Biopharma shareholders approve 3M-share increase and evergreen provision in equity plan
Immix Biopharma, Inc.
- Shareholders approved increasing omnibus equity plan shares by 3,000,000 to 4,934,561 total.
- Evergreen provision adopted: automatic annual increase of 5% of outstanding shares on Jan 1 for 10 years from 2025.
- All eight director nominees elected; ratification of KMJ Corbin & Company LLP as auditor passed.
- Meeting had 70.4% of shares present, constituting a quorum.